As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...

Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

A Kyoto-based regenerative medicine company is launching a service that will allow individuals to generate and store induced ...

PSCore platform delivered over 500 characterized iPSC lines during first year of collaborationSAN DIEGO--(BUSINESS WIRE)--iXCells Biotechnologies USA, Inc. (“iXCells”), a leading provider of human ...

GelMEDIX Inc., a biotechnology company developing regenerative therapies to restore vision, and Catalent, Inc., the leader in enabling the development and supply of better treatments for patients ...

On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...

A Kyoto-based regenerative medicine company is launching a service that will allow individuals to generate and store induced ...

Japan’s health ministry has endorsed the first stem-cell therapy derived from induced pluripotent stem cells (iPSCs) for ...